Obesity &Amp; Overweight
Metabolic·MeSH: Overweight
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
1 drug in development·1 company·6 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| UBT251 | UNITED THERAPEUTICS Corp (UTHR) |
Frequently asked questions
How many drugs are in development for Obesity &Amp; Overweight?
BioSniper tracks 1 drug in development for Obesity &Amp; Overweight across 1 company.
How many clinical trials target Obesity &Amp; Overweight?
There are 6 clinical trials targeting Obesity &Amp; Overweight tracked by BioSniper.
What is the prevalence of Obesity &Amp; Overweight?
The estimated prevalence of Obesity &Amp; Overweight is approximately 42000.0 per 100,000 population.
Deep-dive into Obesity &Amp; Overweight
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis